EDTA blood or genomic DNA from both partners; exact sample specifications are confirmed before collection.
FAMILY PLANNING
Family Planning Panel
Assesses both partners together for selected recessive and X-linked conditions that could affect a future child.
Couple-based carrier analysis with joint interpretation.
A combined carrier-risk interpretation and possible reproductive next steps.
Confirmed after selection and sample review.
CLINICAL VALUE
Where this test is strongest
✓Both partners interpreted together
✓Supports reproductive counseling
✓Looks for shared recessive risk
✓Can clarify X-linked risk
LIMITATIONS
What must remain visible
!Carrier status usually does not mean the carrier is affected.
!A negative result leaves residual risk.
GENE & ANALYTICAL SCOPE
Scope confirmed per case
The exact gene set depends on the current family-planning portfolio and is confirmed before testing.
Couple-based carrier screenCase-specific analytical scope+
Current validated gene and variant scope is confirmed in the quotation.
No fixed gene-by-gene list applies to this scope.
BEFORE ORDERING
Confirm the current laboratory specification.
The official case review and quotation confirm eligibility, accepted material, validated coverage and variant classes, consent, turnaround, price, and report pathway.